BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21102646)

  • 1. Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.
    Arrese M
    Nat Rev Endocrinol; 2010 Dec; 6(12):660-1. PubMed ID: 21102646
    [No Abstract]   [Full Text] [Related]  

  • 2. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
    Bugianesi E; Vanni E; Marchesini G
    Curr Diab Rep; 2007 Jun; 7(3):175-80. PubMed ID: 17547834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated hemoglobin and liver disease in diabetes mellitus.
    Schnedl WJ; Wallner SJ; Piswanger C; Krause R; Lipp RW
    Wien Med Wochenschr; 2005 Sep; 155(17-18):411-5. PubMed ID: 16392439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
    Williams KH; Shackel NA; Gorrell MD; McLennan SV; Twigg SM
    Endocr Rev; 2013 Feb; 34(1):84-129. PubMed ID: 23238855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 1. Nonalcoholic fatty liver disease].
    Takamura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):836-44. PubMed ID: 23772495
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of nonalcoholic fatty liver disease in the Americas.
    López-Velázquez JA; Silva-Vidal KV; Ponciano-Rodríguez G; Chávez-Tapia NC; Arrese M; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2014; 13(2):166-78. PubMed ID: 24552858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis and diabetes.
    Caballeria J; Caballeria L
    Endocrinol Nutr; 2016 Oct; 63(8):377-9. PubMed ID: 27423933
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus.
    Bril F; Cusi K
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):765-781. PubMed ID: 27823604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2nd prize in the competition of works in hepatology GSSR 2010 new approaches to treatment of patients with Nash type 2 diabetes].
    V'iuchnova ES; Babina SM
    Eksp Klin Gastroenterol; 2011; (8):91-6. PubMed ID: 22629763
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, nutrition, and liver disease in children.
    Feldstein AE; Patton-Ku D; Boutelle KN
    Clin Liver Dis; 2014 Feb; 18(1):219-31. PubMed ID: 24274876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease.
    Fitzgerald MA
    Nurse Pract; 2007 Feb; 32(2):24-5. PubMed ID: 17264787
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic complications of obesity.
    Diehl AM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):57-68. PubMed ID: 20202579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and diabetes mellitus.
    Adams LA
    Endocr Res; 2007; 32(3):59-69. PubMed ID: 18092195
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus.
    Kim HJ; Cho MH; Park JS; Nam JS; Kang ES; Ahn CW; Cha BS; Lee EJ; Lim SK; Kim KR; Lee HC; Huh KB
    J Korean Med Sci; 2008 Apr; 23(2):256-61. PubMed ID: 18437009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic.
    Ahmed MH; Osman MM
    Br J Hosp Med (Lond); 2006 May; 67(5):267. PubMed ID: 16729640
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
    Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
    Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.